Key result
FDG-PET/CT detected local relapse in 100% (7/7) of patients and distant metastases in 77% (10/13) of pediatric sarcoma patients with suspected recurrence.
Why the study?
Does FDG-PET/CT improve the detection of local recurrence and distant metastases in children with sarcoma compared to conventional imaging?
Population
19 children with sarcoma evaluated for suspected local relapse or distant metastases
Comparison
Positron emission tomography/computed tomography… vs Conventional imaging modalities and surgical…
Design
Cohort
Follow-up
at least 3 months
Authors
Loading...
Supports FDG-PET/CT as complementary for suspected recurrence in pediatric sarcomas; leaves open prospective comparison to conventional imaging.
Observational (n=19)
Does FDG-PET/CT improve the detection of local recurrence and distant metastases in children with sarcoma compared to conventional imaging?
FDG-PET/CT is a useful complementary imaging modality for detecting recurrent pediatric sarcomas, particularly at the primary site.
Arush et al. (2007) conducted an observational in Pediatric sarcoma (n=19). FDG-PET/CT vs. Conventional imaging (CT, MRI, bone scans) was evaluated on Detection of local recurrence and distant metastases. FDG-PET/CT detected local relapse in 100% (7/7) of patients and distant metastases in 77% (10/13) of pediatric sarcoma patients with suspected recurrence.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: